Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

LIDAK DISMISSES PRESIDENT/CEO

Nov. 7, 1991

FDA APPROVES EXPANDED DERMAGRAFT TRIALS

Nov. 7, 1991

IMMUNEX TO TEST IL-1 AGAINST ALLERGENS

Nov. 6, 1991

CAT ALLERGY PROTEIN CLONED

Nov. 6, 1991

LILLY CANADA TO ACQUIRE STAKE IN ALLELIX

Nov. 6, 1991

ISIS FILES ITS SECOND OFFERING OF THE YEAR

Nov. 6, 1991

MUREX ANGLES FOR WELLCOME DIAGNOSTICS BUSINESS

Nov. 6, 1991

ORGANOGENESIS FILES FOR PUBLIC OFFERING

Nov. 6, 1991

GTI CRADA FOR PULMONARY DISEASES

Nov. 6, 1991

IMMUNOGEN RETURNS TO OFFERINGS WELL

Nov. 5, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...